Cystic Fibrosis (CF) Flow Rates Study

Completed

• Conditions: Cystic Fibrosis

• Registration Number: NCT00779077
• Lead Sponsor: Syntara

Brief Summary

We wish to measure the inspiratory flow and volumes generated by the subjects inhaling from a spirometer with a high resistance dry powder inhaler in series in subjects with cystic fibrosis.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2008-10-23
• Study First Submitted QC: 2008-10-23
• Study First Posted: 2008-10-24
• Study Start: 2009-01
• Primary Completion: 2009-02
• Study Completion: 2009-02
• Status Verified: 2009-04
• Last Update Submitted: 2009-04-22
• Last Update Posted: 2009-04-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

• CF
• FEV1 ≥ 30% and < 90% predicted

Exclusion Criteria

• Be considered "terminally ill" or listed for lung transplantation
• Have had a lung transplant
• Have had a significant episode of haemoptysis (>60 ml) in the three months prior to enrolment
• Have had a myocardial infarction in the three months prior to enrolment
• Have had a cerebral vascular accident in the three months prior to enrolment
• Have had major ocular surgery in the three months prior to enrolment
• Have had major abdominal, chest or brain surgery in the three months prior to enrolment
• Have a known cerebral, aortic or abdominal aneurysm
• Be breast feeding or pregnant
• Be using beta blockers
• Have unstable asthma

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
inspiratory flow rates	single visit

Secondary Outcome Measures

Name	Time	Method
inspiratory volumes	single visit